Showing results (271-280 of 501) with videos related to
Sort By:
Pageof 51
Nature|April 25, 2014
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancerIrfan A Asangani, Vijaya L Dommeti, Xiaoju Wang, et al.Cancer Research|October 23, 2022
Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2Patrick C O'Leary, Huadong Chen, Yagmur U Doruk, et al.Nature Communications|December 13, 2024
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostateXuanrong Chen, Michael A Augello, Deli Liu, et al.The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.Science (New York, N.Y.)|December 17, 2016
CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cellsS John Liu, Max A Horlbeck, Seung Woo Cho, et al.Nature|December 13, 2023
Base-editing mutagenesis maps alleles to tune human T cell functionsRalf Schmidt, Carl C Ward, Rama Dajani, et al.The Prostate|June 3, 2022
Genomic biomarkers to guide precision radiotherapy in prostate cancerPhilip Sutera, Matthew P Deek, Kim Van der Eecken, et al.The Journal of Clinical Investigation|December 22, 2012
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypesMichael A Augello, Craig J Burd, Ruth Birbe, et al.Neoplasia (New York, N.Y.)|August 28, 2016
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerSudhanshu Shukla, Xiang Zhang, Yashar S Niknafs, et al.Pageof 51